Neuroendocrine tumor liver metastases : use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response

• Main Authors: Miyazaki, K., Orton, M. R., Davidson, R. L., d'Arcy, J. A., Lewington, V., Koh, T. S., Thng, C. H., Leach, M. O., Collins, D. J., Koh, D.-M.
• 其他作者: School of Electrical and Electronic Engineering
• 格式: Article
• 語言: English
• 出版: 2013
• 主題: DRNTU::Engineering::Electrical and electronic engineering
• 在線閱讀: https://hdl.handle.net/10356/84807; http://hdl.handle.net/10220/12276

Purpose: To evaluate dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging for monitoring and assessing treatment response in patients with neuroendocrine liver metastases treated using yttrium 90 (90Y)-labeled octreotide (90Y-DOTATOC). Materials and Methods: The study was approved by...